SB948
Pharmacist scope of practice; initiation of treatment for certain diseases and conditions.
Summary
As Passed Both Chambers. Pharmacist scope of practice; initiation of treatment for certain diseases and conditions.
Allows pharmacists to initiate treatment with, dispense, or administer controlled substances or devices for the initiation of treatment of group A Streptococcus bacteria infection, influenza virus infection, COVID-19 virus infection, and urinary tract infection to persons 18 years of age or older with whom the pharmacist has a bona fide ... (More) pharmacist-patient relationship in accordance with regulations set forth by the Board of Pharmacy. The bill directs the Board of Pharmacy to adopt a statewide protocol for the initiation of treatment with and dispensing and administering of drugs and devices by pharmacists in accordance with the provisions of the bill by November 1, 2023. The bill provides that such protocol shall be developed by a work group consisting of representatives from the Board of Pharmacy, the Board of Medicine, and the Department of Health and directs the Board of Pharmacy to adopt emergency regulations to implement the provisions of the bill. This bill is identical to HB 2274. (Less)-
Bill History
- 01/06/2023 - Senate: Prefiled and ordered printed; offered 01/11/23 23102717D
- 01/06/2023 - Senate: Referred to Committee on Education and Health
- 01/11/2023 - Senate: Assigned Education sub: Health Professions
- 01/13/2023 - Senate: Impact statement from DPB (SB948)
- 01/16/2023 - Senate: Senate subcommittee amendments and substitutes offered
- 01/19/2023 - Senate: Senate committee, floor amendments and substitutes offered
- 01/19/2023 - Senate: Reported from Education and Health with amendments (14-Y 0-N)
- 01/19/2023 - Senate: Senate committee, floor amendments and substitutes offered
- 01/20/2023 - Senate: Constitutional reading dispensed (38-Y 0-N)
- 01/23/2023 - Senate: Read second time
- 01/23/2023 - Senate: Reading of amendments waived
- 01/23/2023 - Senate: Committee amendments agreed to
- 01/23/2023 - Senate: Engrossed by Senate as amended SB948E
- 01/23/2023 - Senate: Printed as engrossed 23102717D-E
- 01/24/2023 - Senate: Impact statement from DPB (SB948E)
- 01/24/2023 - Senate: Read third time and passed Senate (39-Y 0-N)
- 02/09/2023 - House: Placed on Calendar
- 02/09/2023 - House: Read first time
- 02/09/2023 - House: Referred to Committee on Health, Welfare and Institutions
- 02/14/2023 - House: House committee, floor amendments and substitutes offered
- 02/14/2023 - House: Reported from Health, Welfare and Institutions with amendment(s) (12-Y 9-N)
- 02/16/2023 - House: Read second time
- 02/17/2023 - House: Read third time
- 02/17/2023 - House: Committee amendments agreed to
- 02/17/2023 - House: Engrossed by House as amended
- 02/17/2023 - House: Passed House with amendments (65-Y 34-N)
- 02/17/2023 - House: VOTE: Passage (65-Y 34-N) Close Floor Vote
- 02/20/2023 - Senate: House amendments agreed to by Senate (39-Y 1-N)
- 02/23/2023 - Senate: Enrolled
- 02/23/2023 - Senate: Bill text as passed Senate and House (SB948ER)
- 02/23/2023 - Senate: Impact statement from DPB (SB948ER)
- 02/23/2023 - House: Signed by Speaker
- 02/25/2023 - Senate: Signed by President
- 03/02/2023 - Senate: Enrolled Bill Communicated to Governor on March 2, 2023
- 03/02/2023 - Governor: Governor's Action Deadline 11:59 p.m., March 27, 2023
- 03/22/2023 - Governor: Approved by Governor-Chapter 172 (effective 7/1/23)
- 03/22/2023 - Governor: Acts of Assembly Chapter text (CHAP0172)
